This is not the most recent version of the article. View current version (15 JAN 2014)

Intervention Review

Perazine for schizophrenia

  1. Stefan Leucht1,*,
  2. Benno Hartung2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 APR 2006

Assessed as up-to-date: 16 FEB 2006

DOI: 10.1002/14651858.CD002832.pub2


How to Cite

Leucht S, Hartung B. Perazine for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD002832. DOI: 10.1002/14651858.CD002832.pub2.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    Heinrich-Heine-Universitaet Duesseldorf, Institut fuer Rechtsmedizin, Dusselfdorf, Germany

*Stefan Leucht, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Möhlstr. 26, München, 81675, Germany. Stefan.Leucht@lrz.tu-muenchen.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2006

SEARCH

This is not the most recent version of the article. View current version (15 JAN 2014)

  1. You have free access to this content

    Current Version

    Perazine for schizophrenia

    Stefan Leucht, Bartosz Helfer and Benno Hartung

    Version of Record online: 15 JAN 2014 | DOI: 10.1002/14651858.CD002832.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Perazine for schizophrenia

    Stefan Leucht and Benno Hartung

    Version of Record online: 19 APR 2006 | DOI: 10.1002/14651858.CD002832.pub2

  2. Version 1

    Perazine for schizophrenia

    S Leucht and B Hartung

    Version of Record online: 21 JAN 2002 | DOI: 10.1002/14651858.CD002832